| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.007 |